文献速递糖尿病

REWIND试验中认知障碍新指标与心血管结局的关系

Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在REWIND试验8772名完成基线MoCA与DSST的2型糖尿病患者中,905名(10.3%)存在基线实质性认知障碍(SCI)。SCI与MACE(未校正HR 1.34)及卒中或死亡(未校正HR 1.60)相关,而基于两评分几何均数的SCI-GM关联更强(MACE未校正HR 1.61,卒中或死亡未校正HR 1.85),且SCI-GM经多达10项危险因素校正后仍显著。

要点

  • 基线SCI患者905名(10.3%),MACE未校正HR 1.34(95%CI 1.11,1.62),卒中或死亡未校正HR 1.60(95%CI 1.33,1.91)。
  • SCI-GM与MACE未校正HR 1.61(95%CI 1.28,2.01),卒中或死亡未校正HR 1.85(95%CI 1.50,2.30)。
  • 仅SCI-GM在校正多达10项SCI危险因素后仍与结局显著相关。

核心结论

  • 在国家标准化下,SCI-GM是REWIND试验2型糖尿病人群心血管事件的强独立预测因子。

研究设计与样本

  • REWIND试验中完成基线MoCA和DSST的参与者共8772名,分析认知评分与MACE及卒中或死亡的关系。

主要发现

  • 905名(10.3%)基线SCI患者较7867名(89.7%)未受影响者MACE发生率更高(未校正HR 1.34;95%CI 1.11,1.62;P=0.003)。
  • SCI患者卒中或死亡未校正HR 1.60(95%CI 1.33,1.91;P<0.001)。
  • SCI-GM与MACE未校正HR 1.61(95%CI 1.28,2.01;P<0.001),与卒中或死亡未校正HR 1.85(95%CI 1.50,2.30;P<0.001)。
  • SCI-GM在校正多达10项SCI危险因素的模型中所有关联仍显著,而SCI则不然。

关键数值与推荐

  • SCI定义为MoCA或DSST基线评分低于该国特定均值≥1.5 SD。
  • SCI-GM定义为两评分几何均数低于该国平均几何均数≥1.5 SD。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Low cognitive scores are risk factors for cardiovascular outcomes. Whether this relationship is stronger using novel cognitive indices is unknown. METHODS: Participants in the Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial who completed both the Montreal Cognitive Assessment (MoCA) score and Digit Substitution Test (DSST) at baseline (N = 8772) were included. These scores were used to identify participants with baseline substantive cognitive impairment (SCI), defined as a baseline score on either the MoCA or DSST ≥ 1.5 SD below either score's country-specific mean, or SCI-GM, which was based on a composite index of both scores calculated as their geometric mean (GM), and defined as a score that was ≥ 1.5 SD below their country's average GM. Relationships between these measures and incident major adverse cardiovascular events (MACE), and either stroke or death were analyzed. RESULTS: Compared with 7867 (89.7%) unaffected participants, the 905 (10.3%) participants with baseline SCI had a higher incidence of MACE (unadjusted hazard ratio [HR] 1.34; 95% CI 1.11, 1.62; P = 0.003), and stroke or death (unadjusted HR 1.60; 95% CI 1.33, 1.91; P < 0.001). Stronger relationships were noted for SCI-GM and MACE (unadjusted HR 1.61; 95% CI 1.28, 2.01; P < 0.001), and stroke or death (unadjusted HR 1.85; 95% CI 1.50, 2.30; P < 0.001). For SCI-GM but not SCI, all these relationships remained significant in models that adjusted for up to 10 SCI risk factors. CONCLUSION: Country-standardized SCI-GM was a strong independent predictor of cardiovascular events in people with type 2 diabetes in the REWIND trial.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Cukierman-Yaffe T, Gerstein HC, Basile J, et al. Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial. J Clin Endocrinol Metab. 2022. PMID: 35446415. doi:10.1210/clinem/dgac200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。